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Objectives: The reference standard technique for the reconstruction of the extrahepatic biliary tree is
Roux-en-Y hepaticojejunostomy. This procedure is not without complications and may not be feasible in
some patients. This project sought to evaluate a novel approach for repairing common bile duct injuries
with a biosynthetic graft. This allows for the reconstruction of the anatomy without necessitating an
intestinal bypass.
Methods: Study subjects were 11 mongrel hounds. Utilizing an open approach, the common bile duct
was transected in each animal. A 1-cm graft of a synthetic bioabsorbable prosthesis was interposed over
a 5-Fr pancreatic stent and sewn in place as an interposition tube graft with absorbable sutures.
Intraoperative cholangiograms and monthly liver function tests were completed. Animals were killed at 6,
7, 8, 10 and 12 months.
Results: The first five animals were killed early in the process of protocol development. One animal
developed obstructive symptoms and was killed on postoperative day 14. The next five animals were
longterm survivors without evidence of clinically significant graft stenosis. Mean alkaline phosphatase and
total bilirubin were normal, at 140 U/l and 0.2 mg/dl, respectively. Histology showed the complete
replacement of the graft with native tissue at 6 months.
Conclusions: Biliary reconstruction using a synthetic bioabsorbable prosthetic as an interposition tube
graft is feasible based on initial results.
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Introduction
The introduction of laparoscopic techniques to address biliary
pathology has been associated with a marked increase in the
number of iatrogenic common bile duct (CBD) injuries.1,2 Not-
withstanding the technological advances in endoscopic and mini-
mally invasive surgical techniques, these complications necessitate
an open Roux-en-Y hepaticojejunostomy reconstruction. This
surgery is not without morbidities, which can be both acute and
longterm, and may not be feasible in patients with surgically
altered anatomy. The ability to re-establish bilioenteric continuity
in the absence of an enteric bypass offers potential therapeutic
advantages to both patient and surgeon. Select institutions have
attempted to identify alternative therapeutic approaches to recon-
structing the extrahepatic biliary tree with variable degrees of
success.3–8 In this study, a biosynthetic tube graft was interposed
between the transected ends of the CBD, reconstituting the biliary
anatomy without an intestinal bypass.
Materials and methods
Eleven canines, each weighing 20–25 kg, were anaesthetized and
subjected to midline laparotomies. Prophylactic doses of i.v.
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cephazolin were administered preoperatively and for 5 days post-
operatively. The gallbladder was removed in a standard dome-
down fashion. In each animal, a transcystic cholangiogram was
performed to ensure normal anatomy. The CBD was sharply
transected 1 cm distal to the origin of the cystic duct. End-to-end
anastomoses were created proximally and distally to the interpo-
sition graft with interrupted 6–0 absorbable monofilament
sutures over a 5-Fr plastic stent (Fig. 1). Each graft was individu-
ally fashioned with an intraluminal diameter of 3 mm. The mate-
rial used to construct the graft was a proprietary bioabsorbable
mesh composed of a polymer of polyglycolic acid and trimethyl-
ene carbonate (PGA : TMC) and commercially available as Bio-a®
(WL Gore & Associates, Inc., Newark, DE, USA). Following this,
omentum was brought up to the right upper quadrant and placed
over the repair. In animals 2–5, Tisseel® (Baxter International,
Inc., Deerfield, IL, USA) was introduced around the anastomosis.
This step was omitted in subjects 6–11. A layered closure of the
abdomen was performed. No drains were placed.
Animals showing evidence of unrelieved pain or a suspected
compromised repair were evaluated by the attending veterinarian
whose recommendations in relation to the animal’s suitability for
continuation in the study were followed. Monthly liver function
tests (alkaline phosphatase, total bilirubin, gamma-glutamyl
transpeptidase [GGT], aspartate aminotransferase [AST] and
alanine aminotransferase [ALT]) were drawn to assess the level of
insult to the liver. At 6–8 weeks postoperatively, the animals were
placed under general anaesthesia and endoscopic stent removal
attempted.
One animal was killed at each of 6, 7, 8, 10 and 12 months,
respectively. Following re-exploration of the abdomen, a cholan-
giogram was performed. The entirety of the extrahepatic biliary
tree and a liver biopsy were then harvested from the animal, fixed
in 10% neutral buffered formalin and sent to the histopathology
laboratory for sectioning. Macroscopic assessment of the interpo-
sition graft was performed. Microscopic analysis included haema-
toxylin and eosin stains. The bile ducts were evaluated for
evidence of inflammation, epithelialization of the neo-bile duct
and incorporation of the graft into this structure.
Permission from the Ohio State University Medical Center
Institutional Animal Care and Use Committee (IACUC) was
obtained prior to beginning the study.
Results
Eleven animals were enrolled in the study. The first animal devel-
oped an anastomotic leak and was killed on postoperative day
(PoD) 6. The next four dogs developed signs and symptoms con-
sistent with cholangitis. They were killed at 3–6 days after the
initial operation. In all four dogs, Tisseel® had been applied to the
reconstruction. Necropsy showed the anastomoses to be intact,
the stents in place and no evidence of bile extrusion. The sixth
animal developed obstructive symptoms and was killed on PoD
14. At necropsy the stent was found to have migrated proximally
and was no longer across the anastomosis, resulting in an acute
anastomotic stenosis.
The final five animals survived to the predetermined dates of 6,
7, 8, 10 and 12 months post-surgery without complications or
weight loss. In two animals the stent was verified to have passed
spontaneously under fluoroscopy. In two animals the stent was
Figure 1 Post-implantation photograph of graft interposed between
the two cut ends of the native common bile duct
Figure 2 Explanted bile duct, pancreas and duodenum of a 6-month
survivor without gross evidence of the interposed graft. The bracket
denotes the area of graft implantation
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successfully removed endoscopically. In a single animal the stent
had migrated proximal to the anastomosis and could not be
removed without disrupting the repair. In this instance, the stent
was left in place. Necropsy revealed the abdominal cavities to be
without bilious staining and showed that the graft had been
grossly incorporated into the biliary tree (Fig. 2). Necropsy cho-
langiography showed some evidence of a dilated CBD, but no sign
of a clinically significant anastomotic stricture as defined by labo-
ratory abnormalities consistent with biliary obstruction (Fig. 3).
In the animals that completed the study, median total bilirubin
and alkaline phosphatase, AST and GGT remained within normal
limits throughout the study. Median ALT was within normal
ranges except for a minor increase during the third postoperative
month (Table 1).
Histological analysis of the graft at 2 weeks showed increased
thickness of the wall with marked transmural neutrophile and
lymphoplasma cell infiltrate and granulation tissue (Fig. 4A, B). In
the grafted area, ulceration with remaining undigested synthetic
polymers graft admixed with foreign body-type multinucleated
giant cell formation was present. No re-epithelialization was iden-
tified at this time-point. The grafted bile duct at 6 months showed
quite different morphological findings (Fig. 4C). Although focal
erosion with some chronic lymphoplasma cell infiltrate was
present, the majority of the area was lined with a single layer of
re-epithelialized tall columnar cells overlying collagenous connec-
tive tissue. At 8, 10 and 12 months, the bile duct appeared to be no
different from a normal benign bile duct (Fig. 4D, E). Biopsies of
the liver showed no significant pathological changes.
Discussion
Cholelithiasis is a disease process that affects more than 30 million
Americans, resulting in approximately 750 000 surgical interven-
tions for symptomatic relief each year.9 In 1990, Dubois et al.
published a seminal paper describing laparoscopic cholecystec-
tomy as a new and less invasive method to treat symptomatic
gallstone disease.10 This adoption of the laparoscopic approach to
biliary disease was associated with a concurrent increase in the
number of CBD injuries.1,2,11 Furthermore, as the indications and
techniques for liver transplantation have evolved, the number of
biliary tract reconstructions performed annually has continued to
increase.12 It is clear that the reconstruction of the biliary tree in
transplant surgery and extrahepatic biliary pathology resulting
from iatrogenic injury remains a therapeutic challenge for the
hepatobiliary surgeon.
Notwithstanding this, surgical innovation has only nominally
improved the repair of this pathology. A primary end-to-end
anastomosis is commonly eschewed as a result of the stricture rate
associated with a compromised blood supply and potential
tension on the repair. The Roux-en-Y hepaticojejunostomy
remains the reference standard repair and, although this does
effectively reconstitute the bilioenteric anatomy, it requires a
mobile, healthy small bowel and is not without its own complica-
tions, including acute and chronic cholangitis, recurrent
strictures, anastomotic leaks and an increased risk for
cholangiocarcinoma.3,6,9
A review of the literature shows that a small number of insti-
tutions are conducting novel research in an effort to redefine the
Figure 3 Necropsy cholangiogram with evidence of dilation second-
ary to biliary stasis and injection artefact, but without a focal graft-
related stenosis. The bracket denotes the area of graft implantation.
Inset: pre-implantation cholangiogram

















1 0.2 191 45 25 7
3 0.2 75 124 51 5
6 0.2 92 73 31 7
7 0.1 104 88 31 12
8 0.1 90 78 29 7
10 0.2 45 53 26 4
12 0.1 69 45 26 6
aNormal range
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Figure 4 (A, B) Two-week specimen showing a thickened wall with transmural acute and chronic inflammation and granulation tissue. An
ulcer with partial synthetic graft polymers surrounded by foreign body-type multinucleated giant cells is indicated by arrowheads (haema-
toxylin and eosin stain; original magnification ¥4). (B) Polarized light microscopy shows synthetic graft polymers and interconnected pores.
(C) At 6 months, the graft is replaced by collagenous connective tissue and lined with a single layer of tall columnar epithelium. Focal erosion
with chronic inflammation of lymphoplasma cell infiltrate remains in the right upper corner (arrow) (H&E stain; ¥10). (D, E) At 8 months, the
graft area is completely replaced by collagenous connective tissue lined with a single layer of tall columnar epithelium. There is little
inflammation (H&E stain; [D] ¥20, [E] ¥20)
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manner in which this complication is addressed. Several groups
have utilized their experience with vascular repair and tra-
nsitioned that knowledge to the reconstruction of CBD
injuries.4,5,13–16 Many of these studies were complicated by low
patency rates and short lengths of follow-up.4,7,13 Others have
employed different biosynthetic materials as patches or interpo-
sition grafts to bridge the defect in the biliary tree.6–8,17 Similarly to
the aforementioned studies, most were of short duration, which
makes extrapolation to a longterm model difficult.
This study evaluated the use of a new biosynthetic absorbable
graft to bridge a defect in the CBD, reconstituting the extrahepatic
biliary anatomy without an enteric bypass. The initial five animals
were killed early in the process of protocol development. The first
animal experienced an early anastomotic dehiscence, representing
an error in surgical technique. In animals 2–5, an intact and patent
anastomosis was noted on necropsy. In these animals, Tisseel® was
used to help prevent early leaks through the porous graft material
until neoepithelialization could begin. Given the appearance of
the intact anastomoses and the clinical presentation of the
animals, it is hypothesized that the fibrin sealant acted as an infec-
tious nidus for enteric flora, resulting in the development of acute
cholangitis. For this reason, the fibrin sealant was omitted from
the final six animals. The sixth animal experienced an acute anas-
tomotic obstruction secondary to stent migration. In this animal,
the stenosis is presumed to have occurred secondary to normal
postoperative oedema following biliary manipulation and suture
placement. In this case, the oedema is hypothesized to have been
significant enough to occlude drainage through the neo-bile duct.
This animal may have convalesced without complication if not for
the stent movement.
The final five animals all survived for the predetermined periods
of 6, 7, 8, 10 and 12 months, respectively, without complications. In
four subjects the stents were removed or verified as having passed.
In the last animal the stent had migrated to an intrahepatic position
and was no longer across the anastomosis. As this did not influence
the maturation of the repair, this stent positioning was not
addressed further. This is a critical issue as a retained trans-
anastomotic stent would mask a clinically significant stricture,
potentially invalidating conclusions drawn from the study.
Once the technique was refined, there was no evidence of graft
rejection or clinically significant anastomotic stenosis in the final
five animals. Results of initial liver function tests (LFTs) were
elevated in each of these animals. This can be attributed to normal
postoperative surgical oedema at both the anastomosis and dis-
section bed. In the preponderance of cases, LFTs indicated normal
function within 3 weeks (Table 1). This finding is consistent with
the premise that dissection-related oedema was the initiating
factor for the LFT abnormalities. Liver function tests in two
animals showed more persistent minor elevations. However, these
values trended towards normalization to the predetermined time
of death. Perhaps most importantly, no animals showed clinical
evidence of hyperbilirubinaemia or lack of incorporation of the
interposition graft.
In each of the final six animals, the graft successfully functioned
as a tissue scaffold, allowing for ingrowth of native tissues to
reconstitute the bilioenteric anatomy. As illustrated in animal 6,
within 2 weeks of implantation the graft was almost completely
incorporated into a neo-bile duct with evidence of acute inflam-
mation and granulation tissue. At 6 months, only minimal chronic
inflammation was present. Perhaps most importantly, the major-
ity of the bile duct was lined with a single layer of re-epithelialized
tall columnar cells overlying collagenous connective tissue. Histo-
logical assessments of the final three specimens resembled that of
a normal bile duct. In the final five animals, liver biopsies failed to
demonstrate any intrahepatic biliary pathology whatsoever. This
would suggest that the graft was successfully incorporated without
negative sequelae around the anastomosis and within the liver
parenchyma distant to the implantation site.
Conclusions
Biliary reconstruction using a synthetic bioabsorbable prosthetic
as an interposition tube graft is feasible. Anastomotic stenosis
does not appear to be clinically significant, but remains a concern.
Additional study is necessary to ascertain the significance of this
complication and the durability of these preliminary results.
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